Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-723-7434
Dr. Longo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Neurology, 1984 - 1987
NYU Grossman School of MedicineInternship, Transitional Year, 1983 - 1984
University of California (San Diego) Medical CenterFellowship, Neuropathology, 1981 - 1983
UC San DiegoPhD, Neuroscience, 1980 - 1983
University of California San Diego School of MedicineClass of 1981
Certifications & Licensure
CA State Medical License 1985 - 2025
NC State Medical License 2001 - 2019
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Publications & Presentations
PubMed
- Human striatal progenitor cells that contain inducible safeguards and overexpress BDNF rescue Huntington's disease phenotypes.Danielle A Simmons, Sridhar Selvaraj, Tingshuo Chen, Gloria Cao, Talita Souto Camelo
Molecular Therapy. Methods & Clinical Development. 2025-03-13 - p75NTR modulation prevents cellular, cortical activity and cognitive dysfunctions caused by perinatal hypoxia.Bidisha Chattopadhyaya, Karen K Y Lee, Maria Isabel Carreño-Muñoz, Andrea Paris-Rubianes, Marisol Lavertu-Jolin
Brain. 2025-03-04 - Small molecule modulation of p75engages the autophagy-lysosomal pathway and reduces huntingtin aggregates in cellular and mouse models of Huntington's disease.Danielle A Simmons, Namitha Alexander, Gloria Cao, Ido Rippin, Yarine Lugassy
Neurotherapeutics. 2025-03-01
Press Mentions
What Is Pseudobulbar Affect? Symptoms, Causes, Diagnosis, Treatment, and PreventionFebruary 4th, 2023- Small Molecule Lends Big Hope for Brutal Seizure DisorderMarch 4th, 2022
Mind Jumble: Understanding Chemo BrainMay 6th, 2020- Join now to see all
Grant Support
- Stanford Neurology Resident Research TrackNational Institute Of Neurological Disorders And Stroke2010–2012
- P75 Small Molecule Ligands For Alzheimer'S TherapyNational Institute On Aging2007–2012
- Small Molecule Neurotrophin Mimetics To Treat Huntington'S DiseaseNational Institute Of Neurological Disorders And Stroke2010–2011
- Novel LAR Isoforms: A New Class Of Neurotrophic AgentsNational Institute On Aging2002–2003
- Novel LAR Isoforms--A New Class Of Neurotrophic AgentsNational Institute On Aging2001
- Novel LAR Isoforms--A New Class Of Neurotrophic AgentsNational Institute On Aging2000
- Novel LAR Isoforms--A New Class Of Neutrophic AgentsNational Institute On Aging1995–1997
- Aging &Neuronal Death--First Generation Of NGF AnalogNational Institute On Aging1991–1993
- Brain Injury &Transplants: Role Of Nerve Growth FactorNational Institute Of Neurological Disorders And Stroke1987–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
